U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07376603) titled 'IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features' on Jan. 17.
Brief Summary: This observational study aims to evaluate the efficacy and safety of intensity-modulated radiotherapy (IMRT) alone in patients with stage IB nasopharyngeal carcinoma (NPC) without high-risk features. The primary objective is to determine the therapeutic effectiveness of this approach
Study Start Date: Jan. 12
Study Type: OBSERVATIONAL
Condition:
Nasopharyngeal Cancinoma (NPC)
Intensity-modulated Radiotherapy
Stage IB
Intervention:
RADIATION: IMRT along
All patients administered with definitive radiotherapy
Recruitment Stat...